TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe -/- mice

Diabetologia

Volumn 54, Issue 12, 2011, Pages 3157-3167

  Di Bartolo, B A ^a   Chan, J ^a   Bennett, M R ^b   Cartland, S ^a   Bao, S ^d   Tuch, B E ^c   Kavurma, M M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c CSIRO   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Atherosclerosis; Diabetes; TRAIL

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL INFILTRATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DIABETES MELLITUS; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; LIPID DIET; LIPOGENESIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTECTION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANIMALS; APOLIPOPROTEINS E; APOPTOSIS; ATHEROSCLEROSIS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN; ISLETS OF LANGERHANS; LIPOGENESIS; MACROPHAGES; MALE; MICE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRIGLYCERIDES;

EID: 82455175280     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2308-0     Document Type: Article

References (47)

1. J Chan L Prado-Lourenco LM Khachigian MR Bennett BA Di Bartolo MM Kavurma 2010 TRAIL promotes VSMC proliferation and neointima formation in a FGF-2-, Sp1 phosphorylation-, and NFkappaB-dependent manner Circ Res 106 1061 1071 20150555 10.1161/CIRCRESAHA.109.206029 1:CAS:528:DC%2BC3cXksVaqsbw%3D
2. MM Kavurma MR Bennett 2008 Expression, regulation and function of trail in atherosclerosis Biochem Pharmacol 75 1441 1450 18061141 10.1016/j.bcp.2007. 10.020 1:CAS:528:DC%2BD1cXlt1Wjurs%3D (Pubitemid 351375180)
3. MM Kavurma M Schoppet YV Bobryshev LM Khachigian MR Bennett 2008 Trail stimulates proliferation of vascular smooth muscle cells via activation of NF-kappa B and induction of insulin-like growth factor-1 receptor J Biol Chem 283 7754 7762 18178561 10.1074/jbc.M706927200 1:CAS:528:DC%2BD1cXjt1els7Y%3D
4. MM Kavurma NY Tan MR Bennett 2008 Death receptors and their ligands in atherosclerosis Arterioscler Thromb Vasc Biol 28 1694 1702 18669890 10.1161/ATVBAHA.107.155143 1:CAS:528:DC%2BD1cXhtFSms77M
5. SE Lamhamedi-Cherradi S Zheng RM Tisch YH Chen 2003 Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes Diabetes 52 2274 2278 12941766 10.2337/diabetes.52.9.2274 1:CAS:528: DC%2BD3sXntFeqtbo%3D (Pubitemid 37059497)
6. -/- mice Nat Immunol 4 255 260 12577054 10.1038/ni894 1:CAS:528:DC%2BD3sXhsVGitr8%3D (Pubitemid 36322135)
7. P Secchiero R Candido F Corallini, et al. 2006 Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice Circulation 114 1522 1530 17000905 10.1161/CIRCULATIONAHA.106.643841 1:CAS:528:DC%2BD28XpvFGmtbY%3D (Pubitemid 44527008)
8. F Corallini C Celeghini C Rizzardi, et al. 2007 Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro J Cell Physiol 212 89 95 17352408 10.1002/jcp.21006 1:CAS:528:DC%2BD2sXmtVWkt7g%3D (Pubitemid 46867590)
9. M Schoppet AM Sattler JR Schaefer LC Hofbauer 2006 Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis Atherosclerosis 184 446 447 16325821 10.1016/j.atherosclerosis. 2005.10.028 1:CAS:528:DC%2BD28XhsFCruw%3D%3D (Pubitemid 43049733)
10. SH Zhang RL Reddick JA Piedrahita N Maeda 1992 Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E Science 258 468 471 1411543 10.1126/science.1411543 1:CAS:528:DyaK38XmsV2nsr0%3D
11. LM Sedger MB Glaccum JC Schuh, et al. 2002 Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice Eur J Immunol 32 2246 2254 12209637 10.1002/1521-4141(200208)32:8<2246::AID-IMMU2246>3.0.CO;2-6 1:CAS:528:DC%2BD38XmslSltLw%3D (Pubitemid 34965887)
12. E Cretney K Takeda H Yagita M Glaccum JJ Peschon MJ Smyth 2002 Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice J Immunol 168 1356 1361 11801676 1:CAS:528:DC%2BD38XpsFektw%3D%3D (Pubitemid 34094506)
13. EG Bligh WJ Dyer 1959 A rapid method of total lipid extraction and purification Can J Biochem Physiol 37 911 917 13671378 10.1139/o59-099 1:CAS:528:DyaG1MXhtVSgt70%3D
14. DW Garber KR Kulkarni GM Anantharamaiah 2000 A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples J Lipid Res 41 1020 1026 10828095 1:CAS:528:DC%2BD3cXkt1aktbY%3D (Pubitemid 30434334)
15. MP Hermans JC Levy RJ Morris RC Turner 1999 Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes Diabetes 48 1779 1786 10480608 10.2337/diabetes.48.9.1779 1:CAS:528: DyaK1MXmtVaitLs%3D (Pubitemid 29415197)
16. SA Bustin 2000 Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays J Mol Endocrinol 25 169 193 11013345 10.1677/jme.0.0250169 1:CAS:528:DC%2BD3cXnslKgtb8%3D
17. MC Clarke N Figg JJ Maguire, et al. 2006 Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis Nat Med 12 1075 1080 16892061 10.1038/nm1459 1:CAS:528:DC%2BD28XptFCltbg%3D (Pubitemid 44353389)
18. JC Pickup GD Chusney SM Thomas D Burt 2000 Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes Life Sci 67 291 300 10983873 10.1016/S0024-3205(00)00622-6 1:CAS:528:DC%2BD3cXksVOmt74%3D (Pubitemid 30413937)
19. L Piemonti G Calori G Lattuada, et al. 2009 Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals Diabetes care 32 2105 2110 19641159 10.2337/dc09-0763 1:CAS:528:DC%2BD1MXhsVOgtrbK
20. JJ Senn PJ Klover IA Nowak RA Mooney 2002 Interleukin-6 induces cellular insulin resistance in hepatocytes Diabetes 51 3391 3399 12453891 10.2337/diabetes.51.12.3391 1:CAS:528:DC%2BD38Xptl2ntbk%3D (Pubitemid 35403441)
21. S Omoigui 2007 The interleukin-6 inflammation pathway from cholesterol to aging-role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases Immun Ageing 4 1 17374166 10.1186/1742-4933-4-1 (Pubitemid 46534042)
22. RJ Aiello PA Bourassa S Lindsey, et al. 1999 Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 19 1518 1525 10364084 10.1161/01.ATV.19.6.1518 1:CAS:528:DyaK1MXktVKms78%3D (Pubitemid 29263023)
23. E Sehayek S Shefer LB Nguyen JG Ono M Merkel JL Breslow 2000 Apolipoprotein E regulates dietary cholesterol absorption and biliary cholesterol excretion: studies in C57BL/6 apolipoprotein E knockout mice Proc Natl Acad Sci U S A 97 3433 3437 10725355 10.1073/pnas.050016197 1:CAS:528:DC%2BD3cXitlWqt7o%3D (Pubitemid 30183320)
24. CK Roberts K Liang RJ Barnard CH Kim ND Vaziri 2004 HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X Kidney Int 66 1503 1511 15458444 10.1111/j.1523-1755.2004.00914.x 1:CAS:528:DC%2BD2cXpsVShurc%3D (Pubitemid 39298383)
25. L Jia JL Betters L Yu 2010 Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport Annu Rev Physiol 73 239 259 10.1146/annurev-physiol-012110-142233
26. P Secchiero F Corallini C Ceconi, et al. 2009 Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction PloS one 4 e4442 19221598 10.1371/journal.pone.0004442
27. S Volpato L Ferrucci P Secchiero, et al. 2011 Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults Atherosclerosis 215 452 458 21122855 10.1016/j.atherosclerosis.2010.11.004 1:CAS:528:DC%2BC3MXkt1egtLs%3D
28. P Secchiero F Corallini A Pandolfi, et al. 2006 An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction Am J Pathol 169 2236 2244 17148684 10.2353/ajpath.2006.060398 1:CAS:528:DC%2BD2sXhvV2ntA%3D%3D (Pubitemid 351181981)
29. RW Stout 1987 Insulin and atheroma-an update Lancet 1 1077 1079 2883407 10.1016/S0140-6736(87)90495-8 1:STN:280:DyaL2s3gtVCgug%3D%3D
30. MJ Garcia PM McNamara T Gordon WB Kannel 1974 Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study Diabetes 23 105 111 4359625 1:STN:280:DyaE2c%2FovF2quw%3D%3D
31. K Mori Y Ikari S Jono, et al. 2011 Association of serum TRAIL level with coronary artery disease Thromb Res 125 322 325 10.1016/j.thromres.2009.11.024
32. JW Choi JS Song SH Pai 2004 Associations of serum TRAIL concentrations, anthropometric variables, and serum lipid parameters in healthy adults Ann Clin Lab Sci 34 400 404 15648780 1:CAS:528:DC%2BD2MXktlKjtQ%3D%3D (Pubitemid 40040960)
33. E Dirice AD Sanlioglu S Kahraman, et al. 2009 Adenovirus-mediated TRAIL gene (Ad5hTRAIL) delivery into pancreatic islets prolongs normoglycemia in streptozotocin-induced diabetic rats Hum Gene Ther 20 1177 1189 19572802 10.1089/hum.2009.039 1:CAS:528:DC%2BD1MXhtlSjsbfI
34. G Zauli B Toffoli MG di Iasio C Celeghini B Fabris P Secchiero 2010 Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes Diabetes 59 1261 1265 20185810 10.2337/db09-1771 1:CAS:528:DC%2BC3cXmtFegtrg%3D
35. RP Robertson HJ Zhang KL Pyzdrowski TF Walseth 1992 Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations J Clin Invest 90 320 325 1644911 10.1172/JCI115865 1:CAS:528:DyaK38XlsVeqt74%3D
36. S Devaraj N Glaser S Griffen J Wang-Polagruto E Miguelino I Jialal 2006 Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes Diabetes 55 774 779 16505242 10.2337/diabetes.55.03.06.db05-1417 1:CAS:528:DC%2BD28XisVWisLs%3D (Pubitemid 43343235)
37. CJ Binder MK Chang PX Shaw, et al. 2002 Innate and acquired immunity in atherogenesis Nat Med 8 1218 1226 12411948 10.1038/nm1102-1218 1:CAS:528:DC%2BD38XotlWmu74%3D (Pubitemid 35373552)
38. SW Altmann HR Davis Jr LJ Zhu, et al. 2004 Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption Science 303 1201 1204 14976318 10.1126/science.1093131 1:CAS:528:DC%2BD2cXhsVWgtbc%3D (Pubitemid 38233587)
39. JP Davies C Scott K Oishi A Liapis YA Ioannou 2005 Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia J Biol Chem 280 12710 12720 15671032 10.1074/jbc.M409110200 1:CAS:528:DC%2BD2MXislygsr0%3D
40. J Marks NJ Carvou ES Debnam SK Srai RJ Unwin 2003 Diabetes increases facilitative glucose uptake and GLUT2 expression at the rat proximal tubule brush border membrane J Physiol 553 137 145 12963802 10.1113/jphysiol.2003. 046268 1:CAS:528:DC%2BD2cXitlSjuw%3D%3D (Pubitemid 37483922)
41. F Rencurel G Waeber B Antoine, et al. 1996 Requirement of glucose metabolism for regulation of glucose transporter type 2 (GLUT2) gene expression in liver Biochem J 314 Pt 3 903 909 8615787 1:CAS:528:DyaK28XhvFyjt7g%3D (Pubitemid 26097754)
42. SS Im SY Kang SY Kim, et al. 2005 Glucose-stimulated upregulation of GLUT2 gene is mediated by sterol response element-binding protein-1c in the hepatocytes Diabetes 54 1684 1691 15919789 10.2337/diabetes.54.6.1684 1:CAS:528:DC%2BD2MXltVaitrs%3D (Pubitemid 40770758)
43. C Yokoyama X Wang MR Briggs, et al. 1993 SREBP-1, a basic-helix-loop- helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene Cell 75 187 197 8402897 1:CAS:528:DyaK2cXkslajuw%3D%3D (Pubitemid 23306032)
44. E Ivan JJ Khatri C Johnson, et al. 2002 Expansive arterial remodeling is associated with increased neointimal macrophage foam cell content: the murine model of macrophage-rich carotid artery lesions Circulation 105 2686 2691 12045177 10.1161/01.CIR.0000016825.17448.11 (Pubitemid 34596048)
45. V Watt J Chamberlain T Steiner S Francis D Crossman 2011 TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice Atherosclerosis 215 348 354 21324463 10.1016/j.atherosclerosis.2011.01.010 1:CAS:528:DC%2BC3MXkt1egtrc%3D
46. JE Kanter F Johansson RC LeBoeuf KE Bornfeldt 2007 Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? Circ Res 100 769 781 17395883 10.1161/01.RES.0000259589. 34348.74 1:CAS:528:DC%2BD2sXjtlWnu7g%3D (Pubitemid 46555682)
47. F Johansson F Kramer S Barnhart, et al. 2008 Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice Proc Natl Acad Sci U S A 105 2082 2087 18252823 10.1073/pnas.0709958105 1:CAS:528:DC%2BD1cXitl2lsrg%3D (Pubitemid 351439468)